Evogene
Business Services · Israel · 51-200 Employees
View Company Info for Free
Overview
Headquarters
13 Gad Feinstein St. Park Rehovot, Rehov...Phone Number
+97289311900Website
www.evogene.comRevenue
<$5 MillionStock Symbol
EVGNIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
1
1
1
1
1
About Evogene
Evogene is a computational chemistry company that develops artificial intelligence–driven technologies for the discovery and design of novel small molecules for pharmaceutical and agricultural applications. The company leverages its proprietary AI platform to optimize molecule design, accelerate research and development, and improve the transition of scientific discoveries into practical, commercially viable products through strategic collaborations and internal innovation initiatives.Explore more
Evogene Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Evogene your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Evogene launches new products
Click to see if Evogene had a recent Job posting/layoffs
Check if Evogene has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Evogene is spiking on competitors!
Funding: Get notified immidiatlly once Evogene has new funding data
Earning: See what the market has to say on Evogene recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Evogene
Evogene, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Evogene is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Evogene is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Evogene.
Evogene financials insights
Gather financial insights about Evogene, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$5M
2020
Share Placement
$10M
Evogene Tech Stack
A closer look at the technologies used by Evogene
See more technologies
Most Recent Scoops
Project
, according to a high-level source in medical, has completed initiatives related to computer-assisted coding within the last twelve months.
Machine Learning, Software, Language Technology, Artificial Intelligence, Language
Person-Based
Partnership, Research & Development, Pharmaceuticals
Partnership
Evogene has announced its second collaboration with Google Cloud, initiated in February 2026, to integrate advanced AI agents into ChemPass AI using Google Cloud Vertex AI. The collaboration aims to decrease manual errors and automate complex scientific workflows to improve novel small molecule candidate probability of development success.
Cloud, Machine Learning, Artificial Intelligence
Project
Evogene is advancing multiple partnered drug discovery programs with biotechnology companies and academic institutions in human health. ChemPass AI is driving discovery and optimization of candidates that are progressing into testing with partners, with four collaborations publicly disclosed to date.
Medical Research, Pharmaceuticals, Artificial Intelligence
Earnings
Spending/Investment, Finance, Financial Operations
Evogene News & Media
Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
Evogene Ltd. (EVGN) Q2 2026 Earnings Call August 18, 2026 9:00 AM EDTCompany ParticipantsOfer Haviv - CEO, President & DirectorNir NimrodiPolina Ravzin...Evogene Reports Second Quarter and First Half 2026 Financial Results
Company continues strategic transformation, initiated in 2025, into a focused, AI-driven computational chemistry company, with significant progress across pharmaceutical and agricultural product development programs Cash burn expected to decline to approximately $8.5–$9.5 million in 2026,...Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
Zoom conference call scheduled for August 18, 2026, at 9:00 AM ET REHOVOT, Israel, Aug. 14, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and...Evogene Schedules Second Quarter 2026 Financial Results Release
Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Evogene
Sign Up For FreeTo access detailed company insights
Evogene is a computational chemistry company that develops artificial intelligence–driven technologies for the discovery and design of novel small molecules for pharmaceutical and agricultural applications. The company leverages its proprietary AI platform to optimize molecule design, accelerate research and development, and improve the transition... Read More
